机译:乳腺癌病理特征,HER2蛋白表达与HER2和CEP17拷贝数之间的关系:生物学和方法学上的考虑
Department of Pathology, Ghent University Hospital, De Pintelaan 185, Gent 9000, Belgium Belgium,Ghent University Hospital, Ghent, Belgium;
Department of Pathology, Ghent University, Ghent, Belgium,Ghent University Hospital, Ghent, Belgium;
Ghent University Hospital, Ghent, Belgium;
Department of Gynecology, Ghent University Hospital, Ghent, Belgium;
Department of Gynecology, Ghent University Hospital, Ghent, Belgium;
Ghent University Hospital, Ghent, Belgium;
Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium;
Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium;
Department of Pathology, Ghent University, Ghent, Belgium;
Department of Pathology, Ghent University, Ghent, Belgium,Ghent University Hospital, Ghent, Belgium;
机译:HER2 / CEP17比率为2.0或更大的乳腺癌,平均HER2拷贝数小于每种细胞的4.0:频率,免疫组织化学相关性和临床病理特征
机译:早期乳腺癌血清HER2胞外域水平,组织HER2表达与临床病理参数的关系
机译:HER2基因状态与曲妥珠单抗耐药相关的潜在潜在生物学特征的关系及其对接受曲妥珠单抗辅助治疗的乳腺癌患者生存的影响
机译:HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关:回顾性和多中心研究
机译:HER2Delta16:一种肿瘤特异性癌基因,可驱动HER2 +乳腺癌的肿瘤发生和曲妥珠单抗。
机译:乳腺癌患有HER2 IHC2 +和鱼HER2 / CEP17比率≥2.0和平均HER2基因拷贝数4.0每肿瘤细胞:HER2 mRNA过表达是一个罕见的事件
机译:HER2-低乳腺癌的临床,病理和PAM50基因表达特征
机译:HER2过表达内源性抑制因子在乳腺癌中的表达